SARS-CoV-2 & Influenza A/B Detection Kit( Direct Fluorescence PCR)

A multiplex nucleic acid detection kit for simultaneous identification of SARS-CoV-2 (2019-nCoV) and influenza A and B viruses using fluorescent PCR methodology. It enables rapid co-infection diagnosis.

Multiplex real-time PCR kit for simultaneous detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B RNA. Intended for laboratory-trained personnel using nasopharyngeal, oropharyngeal, or sputum specimens.

SARS-CoV-2 Nucleic Acid Detection Kit using fluorescent PCR method for rapid and accurate identification of COVID-19 infection. The kit enables qualitative detection of viral RNA in respiratory specimens, supporting clinical diagnosis and epidemiological surveillance. Designed for laboratory use with high sensitivity and specificity.

Multiplex PCR test kit for simultaneous detection of COVID-19, Influenza A, and Influenza B nucleic acids. Designed for rapid respiratory pathogen identification in clinical and laboratory settings. Delivers high sensitivity and specificity for differential diagnosis of acute respiratory infections.

This diagnostic kit detects SARS-CoV-2 (COVID-19), Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus using PCR-fluorescence technology. Influenza A viruses are most likely to cause epidemic outbreaks due to proneness to genetic mutations, increasing infectivity and pathogenicity, often causing worldwide periodic epidemics. Influenza B viruses often cause local outbreaks. Respiratory syncytial virus is the most common and important pathogen of lower respiratory tract infections in infants and young children, easily causing bronchiolitis and pneumonia with serious complications.

Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.

Multiplex real-time PCR assay for simultaneous detection of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus. Facilitates rapid differential diagnosis of respiratory viral infections.

PCR-based nucleic acid detection kit for COVID-19 diagnosis using fluorescent probe technology. Designed for rapid and accurate identification of SARS-CoV-2 in clinical respiratory samples. Enables quantitative and qualitative analysis in laboratory and point-of-care settings.

Real-time PCR kit for simultaneous detection of Influenza A, Influenza B, SARS-CoV-2, and HRSV a/b with RNase P internal control. CE IVDR-marked and ISO 13485-certified for clinical respiratory pathogen identification. Supports singleplex and multiplex testing protocols for infectious disease diagnostics.

A nucleic acid detection kit for identifying SARS-CoV-2 virus using fluorescent PCR methodology. The kit is designed for rapid COVID-19 diagnosis in clinical and screening applications.

A nucleic acid detection kit for the identification of SARS-CoV-2 (2019-nCoV) using fluorescent PCR methodology. It enables rapid diagnosis of COVID-19 infections.

A diagnostic test kit for the detection of influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit is designed for rapid identification of influenza virus infections.